Studies ofchildhood anxiety disorders have increased in recent years, but the clinical implications ofthe work are sometimes difficult to discern. This paper reviews salientfindings (related to the assessment and management ofanxious children) published in the last 5 years. The high comorbidity among disorders, the occurrence ofdifferent disorders in the same childover time, recent changes in diagnostic categories, the availability ofnew anxiety measures, and poor correspondence between parent and child reports ofsymptoms all underscore the needfor thorough assessment. Increasing evidence supports cognitive-behavioural treatments for anxiety disorders, alone or in combination with pharmacotherapy. Other important aspects ofmanagement suggested by developmental studies ofanxious children include psychoeducation about constitutionalfactors in the development ofanxiety, interventions to address parental anxiety, parenting advice regarding behaviour management and reduction offamily conflict, and treatment ofchild impairment to decrease the risk ofdepression. Questions requiring further research are identified. (Can J Psychiatry 2000;45:724-730) 
T he recognition of childhood anxiety disorders as prevalent, highly impairing conditions has been relatively recent. Research in this field is sparse but is expanding. This paper will familiarize psychiatrists with recent developments in the study ofchildhood anxiety disorders and places them in the context of previous knowledge about anxious children and their treatment. MEDLINE was searched for Englishlanguage abstracts published between 1996 and 2000 containing the term "anxiety" and limited to human children and adolescents. Selected papers were reviewed, and findings were interpreted in relation to previous knowledge and my own clinical experience.
Epidemiology and Prognosis
Previous studies established a prevalence ofanxiety disorders in children of 10% to 20 % (1) with a slight preponderance of female cases after puberty and a high comorbidity among anxiety disorders (2). Many of these children also developed significant psychosocial impairment. Recent studies have tried to characterize children with specific anxiety disorders and have examined possible developmental relationships among the disorders. Children with separation anxiety disorder (SAD) have been found to be younger and show lower levels of psychosocial maturity than do children with overanxious disorder (now termed generalized anxiety disorder [GAD]) (3) . Children with GAD show high reassurance-seeking and a high comorbidity with SAD in childhood and with depressive disorders in adolescence (4) . These findings have led some to hypothesize a developmental continuum-the same children who meet the criteria for SAD when they are young (and cope through reassurance-seeking behaviour directed at a parent) may meet the criteria for GAD later (iftheir anxiety persists while their coping responses become less parent-focused). However, panic disorder has also been linked to childhood SAD (5) , suggesting that several developmental pathways may emerge from early SAD. The occurrence of different anxiety disorders in the same child over time is supported by a 4-year longitudinal study: while remission ofinitial anxiety disorders was common, 30% of anxious children had developed new psychiatric disorders, primarily anxiety disorders, during the follow-up period (6) .
Risk factors for impairment and poor long-term prognosis have also been sought. Social anxiety has been associated consistently with high functional impairment, high risk of depression, and low social competence (7) (8) (9) . Conversely, high trait anxiety has been correlated with low perceptions of being socially accepted and negative expectancies regarding social situations (10, 11) . These findings suggest that improving anxious children's social functioning should be an important clinical focus.
Other correlates of impairment include psychosocial adversity, depressive symptoms, developmental difficulties (delayed early milestones, speech or communication problems, learning problems), conduct problems, and maternal anxiety (9) . The latter 2 correlates are most predictive ofphobic disorders. Though requiring replication, these findings suggest that helping anxious parents manage behavioural difficulties in their anxious children may improve outcome. Consistent with this hypothesis, families of highly impaired children who consistently refused to go to school were also found to have difficulty actively managing their children's behaviour (12) .
The devastating effect of comorbid depression, regardless of specific anxiety disorder or other risk factors, was convincingly illustrated in a prospective study by Last and colleagues (13) . This group followed children and adolescents with anxiety disorders, with anxiety disorders and comorbid depressive disorders, and with no psychiatric illness (control subjects) over 8 years, to young adulthood. Anxious subjects with no history of depression were less likely than were control subjects to live independently but were otherwise relatively well-adjusted. Anxious, depressed subjects were more likely to report psychological problems and more likely to use mental health resources as young adults than were either anxious or control subjects. In summary, addressing impaired social functioning, behaviour problems, and depression as well as anxiety symptoms is likely to improve anxious children's prognosis.
Diagnosis and Measurement
DSM-IV (14) , recognizing the continuity between anxiety disorders in children and adults, reclassified previously described disorders. The conditions "overanxious disorder" and "avoidant disorder" were eliminated; such children were thought to be diagnosable using the criteria for GAD and social phobia (SP) respectively. The only anxiety disorder that remained unique to childhood was SAD.
The utility ofthe GAD and SP criteria in diagnosing children and adolescents is now being evaluated. GAD criteria appear to have some discriminant validity differentiating GAD children from those with other anxiety disorders (15) , but whether these criteria capture all of the children previously diagnosed with overanxious disorder is unclear. Many highly anxious children do not acknowledge excessive worry, which makes the' A' criterion for GAD somewhat problematic.
The diagnosis of selective mutism, characterized by the failure to speak in specific social situations, is also being reexamined. Evidence exists for a strong association between selective mutism and social phobia; this, and the response of many selectively mute children to anxiolytic medication (16) , has led some authors to suggest that this condition should be reclassified as an anxiety disorder (17, 18) . (It is currently classified under "other disorders of childhood.")
The measurement of anxiety in children is complicated by poor correspondence between children's self-reported anxiety ratings and ratings of their anxiety provided by other informants (19) . Outcome-evaluation studies typically address this dilemma by reporting treatment-related changes separately for child report, parent report, and clinician report. In clinical practice, however, report discrepancies can result in confusion. For example, is the child who does not acknowledge anxiety, but whose parents report many anxiety symptoms, truly anxious? In most cases, it is prudent to assume that he or she is anxious. Children with certain coping styles may tend to minimize their anxiety symptoms because they perceive that such behaviour is socially desirable (20, 21) . In some cases, parental anxiety can contribute to reporting differences (22) .
Reporting differences also highlight the limitations ofrelying exclusively on symptom checklists for assessing anxiety. Clinical interviews of parent and child are essential to a complete diagnostic evaluation. Also, anxiety-related impairment may be a more meaningful measure ofthe severity ofa child's disorder than is the number ofsymptoms. A measure ofchildhood anxiety that includes a clinician rating of impairment-the Children's Anxiety Rating Scale-has recently been developed and is now undergoing psychometric evaluation (23) .
Despite these difficulties, several psychometrically sound measures of anxiety in children have recently become available (23) . The Screen for Child Anxiety Related Emotional Disorders (SCARED) (24) and the Multidimensional Anxiety Scale for Children (MASC) (25) have the best empirical validation to date. The SCARED uses a 38-item Likert-type scale to assess anxiety factors: physical symptoms, panic, general anxiety, social phobia, and separation anxiety. The MASC uses a 39-item Likert-type scale to assess anxiety factors: physical symptoms, social anxiety, harm avoidance, and separation anxiety. Both show high internal consistency, test-retest reliability, and discriminant validity with fair parent-child agreement. Scores on these instruments were recently found to be highly correlated (r = 0.72) in a clinical population (26) . Two older measures of anxiety in children (the State-Trait Anxiety Inventory for Children [STAIC] and the Revised Children's Manifest Anxiety Scale [RCMAS]) have recently been revised and updated.
Anxiety sensitivity is the predisposition to react to autonomic arousal with anxiety and has been linked to panic disorder in adults. This construct is distinct from the other anxiety factors mentioned above and is being increasingly examined in children. The Childhood Anxiety Sensitivity Index (27) is an 18item Likert-type scale that assesses the extent to which children believe anxiety will result in negative consequences using 2 empirically derived subfactors: physical concerns and mental incapacitation concerns. It has been found to predict state anxiety in children following a stair-stepping task designed to provoke autonomic arousal. Although currently used as a research tool, it may eventually prove valuable in identifying children at risk for panic disorder or other anxiety conditions related to autonomic triggers.
Developmental Risk Factors
Behavioural inhibition, an aspect of temperament characterized by a tendency to restrict exploration and avoid novelty, has been previously identified as a risk factor for multiple anxiety disorders in middle childhood (28) . Because of its link to multiple anxiety disorders, however, it was thought to be a nonspecific risk factor for anxiety. Recent investigations have therefore attempted to identify risk factors (either biological or environmental) that are specific to particular disorders.
One approach has been to test anxious children for risk factors specific to particular anxiety disorders in adults. As in adults with panic disorder, changes in respiration with carbon dioxide exposure were found to be greater for anxious children (all types) than for nonanxious control children (29) . Test-related hyperventilation in subjects with high test anxiety has also been confirmed in children (30) . Motor soft signs, known to be elevated in agoraphobic adults, have been found to be increased in children of agoraphobic parents, compared with age-and sex-matched control subjects (31) . By contrast, anxious children did not show the blunted growth hormone responses to clonidine found in many anxious adults (32) . It is unclear whether this finding reflects a true discontinuity between child and adult disorders or a neurophysiological adaptation to anxiety that is not yet present in anxious children.
Anxiety sensitivity has been linked specifically to panic disorder in adults. Children and adolescents with panic disorder reported greater levels of anxiety sensitivity than did youngsters with nonpanic anxiety disorders matched for sex (33) . Self-reported anxiety sensitivity was also correlated with depression in children and adolescents referred for anxiety, even when controlling for other aspects of anxiety (34) .
Anxious adults have been found to selectively attend to and selectively remember threatening stimuli (35) . Several investigators have sought similar cognitive biases in anxious children. To date, they have demonstrated threat-related biases in attention (36, 37) , memory functioning (38) , dichotic listening (39) , and interpretation of ambiguous stimuli (40) in children with anxiety disorders or high trait anxiety. Exposure to threatening stimuli has also been found to interfere in the performance of other cognitive tasks (41) .
Interestingly, many ofthe tasks used also test implicit aspects of cognition. In other words, children are not consciously choosing to attend to or remember threatening stimuli. Their biases appear to be due to subtle aspects of information processing (see 42 for a more complete description). Informing parents of the limited control their children have over these biases can be clinically useful. This information often alleviates parental frustration with a child who appears to dwell on the most upsetting aspects ofevents despite repeated reassurance. Reduced parental frustration in tum alleviates some of the child's anxiety.
Genetic studies offer a second promising approach to understanding the development of anxiety disorders in children. Previous studies of twins and families have found a definite familial contribution to childhood anxiety disorders. Recent family studies have found anxiety disorders to be elevated in children of parents with anxiety disorders or mixed anxiety-depression (43), with social phobia (44) , and with agoraphobia (45) . Conversely, parents of school-refusing children had elevated rates of anxiety and depressive disorders (46) . Many specific genetic loci are now being researched. The dopamine transporter gene (DATI) (47) , genes involved in corticotropin release (48) , and the serotonin transporter gene (HTT) (49) have all been linked to internalizing disorders in children, but their specific contributions to the pathophysiology of childhood anxiety remain to be elucidated. Previous twin studies have established a genetic contribution to childhood anxiety symptoms and to anxiety disorders as a group (50) , and the degree of genetic versus environmental contribution to specific anxiety disorders is now being studied. Ina recent twin study, Topolski and others found that shared environmental effects played a moderate role in SAD but were not significant contributors in overanxious disorder, where genetic influences predominated (51) .
Besides behavioural inhibition, additional aspects of temperament have been found to increase the risk of childhood anxiety disorders. High levels of emotionality predicted case status among siblings (where one sibling had an anxiety disorder) (52) , and obsessive difficult temperament (best described as pervasive rigidity or an extreme lack of adaptability) has also been found to be increased in anxious children (53) . Inhibition itselfmay be a more specific risk factor than was previously believed. Two recent studies, one retrospective study (54) and one prospective study using Kagan's cohort (55) have now linked behavioural inhibition to social anxiety in adolescence, but not to other anxiety disorders.
Environmental studies of risk factors for the early development of anxiety disorders have focused largely on aspects of the parent-child relationship. Parental modelling, for example, has been cited as a possible reason for the association between parent and child anxiety (56) . Onset of anxiety disorders in adolescents has been associated with high family conflict (57) .
Many authors have reported an association between parental rejection and control (tendency to restrict a child's autonomy) and childhood anxiety (58) . Unfortunately, most of their work is based on self-reports from anxious individuals concerning their experiences with parents, raising the possibility of bias due to cognitive distortions associated with anxiety. Caster and others, for example, found that socially anxious adolescents perceived their parents as being more socially conscious and less socially active than nonanxious adolescents did, but there were no differences in parental selfperceptions in these areas (59) . One group in Australia hasaddressed this difficulty by observing families of anxious children engaging in problem-solving discussions. Children's anxious expectations and avoidant coping responses following such discussions were associated with specific parental behaviours during the discussion that subtly fostered suchresponses (60,61).
Kagan's group has associated maternal criticism with child behavioural inhibition, but only in mothers suffering from anxiety disorders, suggesting that nature and nurture may interact in producing inhibition (28) . Interactive effects are also suggested by Kortlander and others, who found that mothers' expectations for their anxious children's coping reflected the actual lower coping ability of the children (62) . Poorer child coping was associated with protective maternal responses, a possible maintaining factor for anxious behaviours.
Finally, the role of attachment as a predictor ofanxiety disorders has been confirmed by an impressive longitudinal study by Warren and others (63) . These investigators assessed psychopathology in 172 adolescents (mean age 17.5 years) who had previously been examined-shortly after birth using a screen for parental psychopathology and several temperament measures and at age 12 months using the Strange Situation Procedure for attachment. One subtype of attachment, termed "anxious/resistant," predicted adolescent anxiety disorders consistently, even after accounting for maternal anxiety and temperament. Some adolescents with other attachment histories also developed anxiety disorders but at significantly lower rates.
A remaining challenge is to integrate developmental and cognitive studies with the affective neuroscience pioneered in adults to develop a more comprehensive understanding of various subgroups ofchildhood anxiety disorder and their developmental trajectories. For example, early childhood risk factors such as behavioural inhibition and attachment status may increase a child's vulnerability to anxiety disorders, but the specific disorder may also relate to neurophysiological characteristics (for example, heightened sensitivity to carbon dioxide in panic disorder) that have only been examined in adults to date. Attempts at theoretical integration are now being proposed (64, 65) .
Clinically, it is often useful to inform families that, at least in part, their child's condition is constitutional. This information tends to relieve parental fears about having caused the child's anxiety and helps the clinician emphasize coping rather than cure as a treatment goal. Families are less likely to become discouraged with treatment if they recognize that their child, though likely to continue to be somewhat more anxious than the average, can learn to cope, to the point where anxiety does not interfere significantly in daily activities.
Psychological Treatment
Cognitive-behavioural treatment (CBT) that combines anxiety management training with enactive exposure has been studied most in relation to anxious children. Its brevity and reproducibility (through the use of standardized manuals) facilitate outcome studies. Three groups of investigators have conducted randomized trials in mixed anxious samples. Kendall and others used the "coping cat" individual treatment model for children aged 9 to 13 years in 2 such trials with waiting-list control subjects (66) . Treated children fared significantly better, with most returning to subclinical levels of anxiety and maintaining their gains at 1 year after treatment. A subgroup (82% oforiginal sample), studied at 3 years after treatment, continued to show improvement.
Using the same treatment model adapted for groups, Mendlowitz and others also showed treatment-related reductions in self-reported anxiety and depression (67) . In this trial, families were randomized to child group only, parent group only, or combined treatment with child and parent groups, with a waiting-list control condition. Relative to the other treatments, combined treatment showed more benefits in fostering children's use of more adaptive coping strategies.
The importance of parental involvement was further examined by Barrett and others, who found no benefit from adding family management to child CBT when the child was evaluated immediately after treatment, but found a significantly greater remission from anxiety disorders at 1 year after treatment (68) . Interestingly, they then related parental anxiety level to treatment differences (69) . Remission from anxiety disorder in the child was greater for the combined treatment only if the parent reported a high level ofanxiety him-or herself, suggesting that anxious parents have particular difficulty helping their children cope with anxiety. Treatment participation is therefore especially important in this group. These investigators also demonstrated the effectiveness ofgroup CBT in a randomized trial (70) .
A recent study ofCBT for school phobia, however, found no differences in school return between CBT and traditional interventions, with both treatments reducing self-reported anxious and depressive symptoms (71) . This finding highlights the need to determine which components ofCBT are most effective in various disorders. For example, in phobic disorders, exposure may be key to therapeutic change, with other anxiety-management strategies being less crucial in determining outcome.
The long-term effects ofCBT on developmental outcomes in anxious children also remain to be elucidated, since most studies follow children for 1 year or less. Further, the treatment's high reliance on verbal ability limits its utility in less verbal children, and the transportability of CBT from academic centres to the community has not yet been demonstrated.
School-based interventions using cognitive techniques with parental involvement have recently been found to reduce "anxiety problems," and prevent the onset of new anxiety disorders in randomized trials (72, 73) . Prevention of anxiety disorders is certainly a laudable aim, but caution is warranted in interpreting these results-these children were not clinically identified. While subclinical levels of anxiety may be amenable to school-based interventions, it is unrealistic to expect school personnel to address the needs ofchildren with severe anxiety disorders. Preventive intervention involving parent and child has also been used to increase social competence (relative to a control group) in preschoolers who appeared anxious and withdrawn (74) . A small open study of students identified as anxious by teachers found a reduction in self-reported anxiety with electromyograph biofeedback and thermal (finger temperature) biofeedback (75) . Students learned to relax their muscles and increase peripheral circulation using these techniques.
Pharmacological Treatment
Specific serotonin reuptake inhibitors (SSRIs) are currently considered to be the medication of choice in childhood anxiety disorders (76) , despite the paucity of outcome studies demonstrating their effectiveness in anxious children. Controlled trials are currently in progress at several sites. Two open trials have shown significant improvement on Clinical Global Impression (CGI) scores with fluoxetine treatment of mixed anxiety disorder samples ( n = 21 and n = 16 respectively) (77, 78) . One open trial showed similar improvement with SSRIs in panic disorder (n = 12) (79) . Side effects were minimal in these studies. Black and Uhde also showed the effectiveness of fluoxetine in a controlled study of selective mutism (80) .
There is no clear evidence of greater effectiveness of one SSRI versus another in treating childhood anxiety. The choice of specific medication is usually made based on likely side effects, duration of action, or family history of response. Authors reviewing pharmacological interventions have suggested that pharmacotherapy be reserved for severe anxiety disorders and the risk/benefit ratio be carefully evaluated, since long-term side effects have not been studied in children or adolescents (76, 81) . The levels at which dosages are effective vary widely in children, so it is prudent to start low and increase gradually depending on side effects and response.
Previous studies showed effectiveness for both tricyclic antidepressants and benzodiazepines in some childhood anxiety disorders (81) , but concerns about the risk of cardiac arrhythmias in the former and addiction in the latter have reduced their use in practice. Benzodiazepines can be useful as adjunctive medications in severe anxiety (79) or for anxiolysis in specific, time-limited anxiety-provoking situations. They can also reduce anxiety temporarily when an SSRI has been started but is not yet effective. The safety and efficacy ofbuspirone is currently being studied for GAD in children.
Pharmacological studies have included varying types of concurrent psychological intervention. Kearney and Silverman compared studies that used only pharmacotherapy with those that added either behaviour therapy or general or supportive psychotherapy (82) . They found a somewhat higher response rate when pharmacotherapy and behaviour therapy were combined. The best combinations of psychological and pharmacological treatments for specific disorders and specific degrees of severity remain to be elucidated.
Comorbidity and Treatment
Comorbidity among childhood anxiety disorders and between anxiety disorders and other psychopathology is highly prevalent. Comorbid depression has been studied most, and various explanatory models exist for the co-occurrence of mood and anxiety disorders in children (83) . A recent study of twins found that most of the covariation between motherrated anxiety and depressive symptoms could be explained by a common set of genes, with some covariation explained by nonshared environmental influences (84) . After examining studies of environmental influences, Brady and Kendall suggested a temporal progression with severe, impairing anxiety predisposing to later depression (85) . Last and others identified depression as a poor prognostic indicator (71) . Indeed, the early treatment of anxiety-related impairment may help prevent depression.
Other comorbidities occurring at rates that exceed chance include attention-deficit hyperactivity disorder (ADHD), oppositional defiant disorder, alcohol abuse, and learning disabilities. Probing for these comorbidities is an important Clinical Implications • Assessing childhood anxiety disorders requires multiple informants, and questionnaires must be interpreted in relation to the overall clinical presentation.
• Cognitive behavioural therapy should be considered as first-line treatment for childhood anxiety disorders.
• Given the many developmental antecedents of childhood anxiety disorders, parent-blaming is unwarranted. Parents should be engaged as partners in the treatment process.
Limitations
• The search for articles reviewed here was limited to Medline. Other articles may exist and be listed only in psychology databases.
• Some studies ofanxious adults that included children may have been overlooked because of the search criteria.
aspect ofassessing anxious children, since their presence can influence treatment decisions. For example, comorbid ADHD may suggest an initial trial of stimulants rather than SSRls-the overall functioning ofmany ofthese children improves with stimulants, whereas SSRI treatment risks behavioural activation. Clinicians may also need to modify some aspects of CBT that require sustained attention. Covert alcohol abuse increases the risks of pharmacotherapy. Undiagnosed learning disabilities can contribute to school-related anxiety, and anxiety-related worries can interfere with cognitive processes (86, 87) . In children with multiple comorbidities, the most disabling symptoms must be prioritized, and families require encouragement to persevere with treatment until the child is returned to age-appropriate functioning in most areas (88) . Etiologic factors underlying each of these comorbidities are currently being studied.
An empirically based understanding of childhood anxiety disorders is now beginning to develop. CBT and pharmacotherapy have been shown to reduce anxiety symptoms, but interventions that address child impairment (social, academic, behavioural), concurrent depression, parental anxiety, and family conflict are also likely to affect long-term prognosis.
Research is needed to elucidate the neural substrates of anxious children's cognitive characteristics (selective attention and memory for threat, anxiety sensitivity, coping deficits), to integrate developmental and neurophysiological theories of anxiety to clarify the etiology of specific disorders, and to locate specific genes that contribute to childhood anxiety disorders. New measures of anxiety must capture child impairment as well as anxiety symptoms and use multiple informants. Randomized controlled trials are needed to evaluate the effectiveness of current pharmacological treatments, particularly SSRIs. The further development of CBT holds some challenges: adapting CBT to children with cognitive limitations (either due to youth or learning impairment), discerning the most effective components ofCBT for specific disorders, improving the transportability of CBT to nonacademic settings, and including systematic treatment for parent-child interactions that can perpetuate anxiety. Finally, the most effective combinations of psychological and pharmacological treatments for specific disorders must be determined.
